Hemostats Market Size, Growth, and Statistic Analysis By 2027

Hemostats Market to 2027 - Global Analysis and Forecasts by Product (Thrombin Based Hemostats, Combination Hemostats, Gelatin Based Hemostats, Collagen Based Hemostats, and Oxidized Regenerated Cellulose Based Hemostats); End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Other End Users); and Geography

  • Report Code : TIPHE100001419
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 145
Buy Now

The Hemostats market was valued at US$ 2,206.00 million in 2019 and it is projected to reach US$ 3,557.41 million by 2027; it is expected to grow at a CAGR of 6.3% from 2020 to 2027.

Hemostats play a basic and fundamental role during surgical procedures as it enables superior blood loss management. The products are has intraoperative and postoperative applications. Hemostats can be used for oozing venous type bleeds, diffusion of raw surface bleeding, bone bleeding, and needle-hole bleeding. The growth of the Hemostats market is attributed to the rising prevalence of chronic diseases, which are leading to increasing number of surgical procedures, number of strategic initiatives taken by governments, and growing number of hospitals. However, the growth of the market is expected to be restrained by lack of product awareness in emerging nations and lack of lucrative reimbursements.

The Hemostats market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.

Lucrative Regions for Hemostats Market



Lucrative Regions for Hemostats in Healthcare Market
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Market Insights

Growing Applications of Hemostats in Healthcare to Drive Hemostats Market Growth

The increasing number of surgical procedures have also increased the use of hemostats. Increase in number of surgeries such as orthopedic surgeries for the replacements of knee & hip help to upsurge the market growth. The surgeries are done for the amputations of the limbs due to the injuries and damages caused by various diseases or road accidents. For instance, as per the U.S. Agency for Healthcare Research and Quality, approximately 600,000 knee replacement surgeries are performed per year in the United States.

Additionally, the number of surgeries is increasing due to the rising musculoskeletal disorders associated with sports, age-related dysfunction, and occupational injuries. For instance, as per the Arthritis Foundation, approximately 54 million adults had been diagnosed with arthritis in 2017. Moreover, nearly 300,000 babies and children have arthritis or a rheumatic condition. 

The rising geriatric population can be a significant factor in increasing the number of surgical procedures. The knee replacement surgeries are being performed in the geriatric population for their deteriorating joints. As per the report, ‘Aging in the United States’ published by Population Reference Bureau’s revealed that the growing population (people 65 and older) are likely to reshape the scenario for the older population in America. The rise in conditions such as rheumatoid arthritis (RA), ankylosing spondylitis (AS), and osteoporosis in elderly age are driving the number of surgeries. For instance, as per the report published in 2018 of Healthline Media, rheumatoid arthritis (RA) affects 41 in every 100,000 people per year, and near round 1.3 million Americans have rheumatoid arthritis. Similarly, according to the International Osteoporosis Foundation (2018), osteoporosis is estimated to affect 200 million women across the world, among which near around one-tenth of women are above the age of 60, one-fifth of women aged more than 70, two-fifths of women aged above 80 and two-thirds of women aged more than 90. Thus, owing to the above mentioned factors, the market for hemostats is anticipated to grow in the forecast period.

The rise in the incidences of sports injuries is contributed by weekend sports players, professional athletes, youngsters, children playing in the societies, and sometimes adults. Most of the sports injuries are orthopedic injuries that include swelling, pain, strain, sprain, fractures, ligament breaks, and others. These injuries are broadly classified as acute and chronic types. The injuries or lesions are caused by sports such as water sports, water soccer (football), cricket, basketball, rugby, athletic games, and others. For instance, according to the Federation Internationale de Football Association (FIFA), the data has revealed that sports injuries are majorly caused by soccer. 

Also, it is estimated that the ankle sprain is the most widely experienced injuries caused by football players worldwide. In the emergency department in the US, approx. 240,000 injuries were treated; among them, nearly 48,810 cases estimated for fractures, and about 79,400 cases were for sprains & strain, and also there were 5,000 cases for the dislocations. 

Besides, as per the report published by BMJ Publishing Group Ltd (2017) stated that nearly 8% of the athletes incurred with one injury during the Olympic Games, in the Rio de Janeiro 2016 Olympic Summer Games. Also, according to the Stanford Children’s Health data published in 2018, in the United States, nearly 3.5 million children and teen has suffered from the injuries of the age group in between 14 years and below. It also reported that the highest rates of injuries occurred in sports involve contact and collisions. Severe injuries happened during individual sports and recreational activities. Additionally, approximately 62% of sports-related injuries occurred during the practice sessions.

Similarly, in cricket, the bowlers are more prone to get injured from the repetitive motion of their legs, elbow, and shoulders. The typical hams and injuries that are being observed are impingement syndromes, rotator cuff tears, ankle sprains, as well as medial ligament injuries to the elbow. Therefore, averagely 10% of the cricketers may suffer from lesions at any point in time in the field and approx. 15% of the incidences are contributed by the fast bowlers. 

Moreover, according to the Stanford Children’s Health, some instances were given, which stated that near 170,000 children between the age group of 5 to 14years were treated for basketball-related injuries in hospital emergency rooms. Likewise, approximately 47,000 children were treated for in-line skating-related injuries. Similarly, around 65,000 children were treated for trampoline-related injuries in hospital emergency rooms.

After analyzing the facts and figures provided by the different organizations, it is expected that the market for the hemostats is likely to experience favorable growth in the forecast period.

Product-Based Insights

In terms of product, the Hemostats market is segmented into thrombin-based hemostats, combination hemostats, gelatin based hemostats, collagen based hemostats and oxidized regenerated cellulose based hemostats. In 2019, the thrombin based hemostats held the largest share of the market, by product.

Hemostats Market, by Product – 2019 and 2027



Hemostats in Healthcare Market, by Product – 2019 and 2027
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

End User-Based Insights

In terms of end user, the Hemostats market is segmented into hospitals & clinics and other end users. The hospitals and clinics held the largest share of end user segment in the global market.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Hemostats Market: Strategic Insights

hemostats-market
Market Size Value inUS$ 2,206.00 Million in 2019
Market Size Value byUS$ 3,557.41 Million by 2027
Growth rateCAGR of 6.3% from 2020-2027
Forecast Period2020-2027
Base Year2020
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

The Hemostats market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.

Hemostats Market – by Product

  • Thrombin Based Hemostats
  • Combination Hemostats
  • Gelatin Based Hemostats
  • Collagen Based Hemostats
  • Oxidized Regenerated Cellulose Based Hemostats

Hemostats Market – by End User

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Other End Users

Hemostats Market – by Geography

  • North America

    • US
    • Canada
    • Mexico
  • Europe

    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)

    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East & Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South America and Central America (SCAM)

    • Brazil
    • Argentina
    • Rest of SCAM

Company Profiles

  • BD
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Integra Life Sciences Corporation
  • Teleflex Incorporated
  • Johnson & Johnson Services, Inc.
  • Biom'up
  • ZMedica, LL
  • Gelita Medical
  • Pfizer Inc.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product ; End User ; and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions


What are hemostats?

Hemostats refers to surgical supplies consisting of hemostatic agents and their delivering systems that are present in the form of pads, sponges, patches, powders, liquids or others. These hemostats are made from various blood clotting materials such as collagen, thrombin, cellulose, gelatin and others.

What are the driving factors for the hemostats market across the globe?

Rise in healthcare insurance providers, technological advancement and growing number of surgery procedures are projected to drive the growth of the global hemostats market during the forecast period. Moreover, growth of healthcare infrastructure among the untapped nations and increased initiatives taken up by governments are expected to fuel the growth of this market during the forecast period.

What is the average cost of Hemostats?

There are various types of hemostats available in the market priced within a range of US$ 5.0 to US$ 150.0 depending upon various factors such as formulation, material composition, application areas, quantity and others.

The List of Companies - Hemostats Market

  1. Johnson & Johnson Services, Inc. (Ethicon LLC)
  2. BD
  3. Baxter
  4. B. Braun Melsungen Ag
  5. Pfizer, Inc.
  6. GELITA MEDICAL
  7. Integra Lifesciences Holdings Corporation
  8. Z-Medica, LLC
  9. Biom’up
  10. Teleflex Incorporated

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Hemostats Market